RELATIONSHIP BETWEEN THE BIOAVAILABILITY AND MOLECULAR PROPERTIES OF ANGIOTENSIN II RECEPTOR ANTAGONISTS

被引:4
|
作者
Trbojevic, Jovana B. [1 ]
Odovic, Jadranka V. [2 ]
Trbojevic-Stankovic, Jasna B. [3 ,4 ]
Nesic, Dejan M. [5 ]
Jelic, Ratomir M. [6 ]
机构
[1] Ivancic & Sinovi Doo, Palmoticeva 13, Belgrade 11000, Serbia
[2] Univ Belgrade, Fac Pharm, Dept Analyt Chem, Belgrade, Serbia
[3] Univ Belgrade, Sch Med, Belgrade, Serbia
[4] Clin Hosp Ctr Dr Dragisa Misovic, Dept Dialysis, Belgrade, Serbia
[5] Univ Belgrade, Inst Med Physiol, Sch Med, Belgrade, Serbia
[6] Univ Kragujevac, Fac Med Sci, Kragujevac, Serbia
关键词
angiotensin II receptor antagonists; lipophilicity; bioavailability; molecular properties; DRUG-LIKE PROPERTIES; POLAR SURFACE-AREA; SOLUBILITY; ABSORPTION; EXCRETION; PHARMACOKINETICS; LIPOPHILICITY; DYSFUNCTION; METABOLISM; DISCOVERY;
D O I
10.2298/ABS150915015T
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In the present study, we investigated the relationships between several molecular properties and bioavailability data for seven of the most commonly prescribed angiotensin II receptor antagonists (also known as angiotensin II receptor blockers (ARBs) or sartans), candesartan, eprosartan, irbesartan, losartan, olmesartan, telmisartan and valsartan. The molecular descriptors of ARBs are:, aqueous solubility (logS values), polar surface area (PSA), molecular weight (Mw), volume value (Vol), lipophilicity (logP values) and the acidity descriptor (pK(a1)). The respective descriptors were calculated using four different software packages. The relevant bioavailability data were obtained from literature. Among calculated molecular descriptors, simple linear regression analysis showed the best correlation between bioavailability data and the lipophilicity descriptor, logP (R-2 = 0.568). Multiple linear regression established good correlations between bioavailability and the lipophilicity descriptor, logP, using the molecular weight, Mw, or the acidity descriptor, pK(a1), as an additional, independent variable (with R-2 = 0.661 and 0.682, respectively). Finally, excluding candesartan from the calculations resulted in a very good correlation (R-2 = 0.852) between the remaining ARB bioavailability and molecular descriptors MlogP and Mw as independent variables, determined by multiple linear regression.
引用
收藏
页码:273 / 278
页数:6
相关论文
共 50 条
  • [1] Angiotensin II receptor antagonists
    Burnier, M
    Brunner, HR
    LANCET, 2000, 355 (9204): : 637 - 645
  • [2] Angiotensin II receptor antagonists
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (01) : 39 - 40
  • [3] MOLECULAR SHAPE COMPARISON OF ANGIOTENSIN-II RECEPTOR ANTAGONISTS
    MASEK, BB
    MERCHANT, A
    MATTHEW, JB
    JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (09) : 1230 - 1238
  • [4] The conformation and activity relationship of benzofuran type of angiotensin II receptor antagonists
    Yoo, SE
    Kim, SK
    Lee, SH
    Kim, NJ
    Lee, DW
    BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (09) : 2311 - 2316
  • [5] The conformation and activity relationship of benzofuran derivatives as angiotensin II receptor antagonists
    Yoo, SE
    Lee, SH
    Kim, SK
    Lee, SH
    BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (02) : 445 - 459
  • [6] Angiotensin II receptor antagonists in hypertension
    Burnier, M
    Brunner, HR
    KIDNEY INTERNATIONAL, 1998, 54 : S107 - S111
  • [7] Comparison of angiotensin II receptor antagonists
    Kirch, W
    Horn, B
    Schweizer, J
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2001, 31 (08) : 698 - 706
  • [8] Anaesthesia and angiotensin II receptor antagonists
    Macdonald, JMS
    ANAESTHESIA, 2000, 55 (10) : 1038 - 1038
  • [9] Angiotensin II receptor antagonists and hypertension
    Mimran, A
    Ribstein, J
    DuCailar, G
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 1999, 21 (5-6) : 847 - 858
  • [10] Angiotensin-II receptor antagonists
    Chung, O
    Unger, T
    INTERNIST, 1996, 37 (05): : 534 - 538